Print this page

F&P Healthcare warns of $5-10M hit in contesting latest Resmed patent allegations

  • font size decrease font size decrease font size increase font size increase font size

Fisher & Paykel Healthcare expects the cost of contesting the latest patent allegations from rival ResMed will cut annual earnings by as much as $10 million in a far-ranging dispute across multiple jurisdictions